FDA Approves Third-Ever Drug for Lupus Nephritis
Obinutuzumab (Gazyva) is the first drug to be approved for lupus nephritis since the approvals of belimumab (Benlysta) in 2020 ...
Obinutuzumab (Gazyva) is the first drug to be approved for lupus nephritis since the approvals of belimumab (Benlysta) in 2020 ...
(MedPage Today) -- The FDA approved oral semaglutide (Rybelsus) to prevent major adverse cardiovascular events (MACE) in high-risk patients with ...
Muscle-invasive bladder cancer patients who are ineligible or refuse cisplatin chemotherapy see “dramatic” improvements in survival outcomes with enfortumab vedotin ...
(MedPage Today) -- At World Sleep 2025, Robson Capasso, MD, of Stanford University in California, challenged the field's reliance on ...
Narcolepsy is not associated with increased risk for mortality of any type, even among patients with a higher prevalence of ...
(MedPage Today) -- Because osteoporosis is more prevalent in women, men with osteoporosis often are overlooked. According to the NIH, ...
(MedPage Today) -- Someone once told me that if you order enough lab tests on a patient, you'll find something. ...
(MedPage Today) -- BERLIN -- Antibody-drug conjugates (ADCs) targeting Trop2 made a strong case as first-line standard of care for ...
(MedPage Today) -- Telehealth medication abortion requests nearly doubled in the months after the Dobbs v. Jackson Women's Health Organization ...
Illustration of Chiron’s ringsDan Durda For the first time, astronomers are watching a ring system form in real time. The ...
Recognizing isolation or fear in a patient is important for hospitalists and may require a little more time with the ...
(MedPage Today) -- Nurse Rod Salaysay works with all kinds of instruments in the hospital: a thermometer, a stethoscope, and ...
(MedPage Today) -- Fewer toddlers developed peanut allergies after guidelines recommended introducing peanut products in infancy, a large primary care ...
Two studies demonstrate that a large proportion of the population has visceral adiposity even at BMIs below the obesity threshold, ...
(MedPage Today) -- CHICAGO -- SGLT2 inhibitor use was linked to reduced progression of in-situ pulmonary adenocarcinoma, an observational study ...
(MedPage Today) -- BERLIN -- Administering bone-modifying agents (BMAs) every 24 weeks after long-term use was a safe and effective ...
Stigma, late diagnosis, and patchy access keep Europe from its HIV milestones. What will it take to close the gap? ...
(MedPage Today) -- Earlier this month, California Gov. Gavin Newsom (D) signed the "Real Food, Healthy Kids Act" into law, ...
Immune-related changes take place in the breasts after breastfeedingSvetlana Repnitskaya/Getty Images Breastfeeding has long been linked to a reduced risk ...
There are many symptoms of perimenopause, but the same signs could point towards different conditions altogetherChristina S. Zhu Like many ...
© 2022 NewsHealth.
© 2022 NewsHealth.